Being studied for effectiveness in Polycystic Ovary Syndrome (PCOS).
First-in-class oral drug.
Description
A first-in-class oral drug that directly enhances embryo implantation and increases pregnancy rates. Unlike current treatments addressing only symptoms, OXO-001 targets infertility and is being studied for effectiveness in Polycystic Ovary Syndrome (PCOS), a common endocrine disorder in women.
Key attributes
Category
Pharmaceuticals
Place of origin
Gurgaon, HR, India
Reviews
Questions & answers
Ask the supplier — answers are visible to all buyers